Investing.com - IsoRay (NYSE:ISR) reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
IsoRay announced earnings per share of $-0.0100 on revenue of $2.51M. Analysts polled by Investing.com anticipated EPS of $-0.0067 on revenue of $3.04M.
IsoRay shares are down 17.21% from the beginning of the year, still down 56.09% from its 52 week high of $0.69 set on November 3, 2021.
IsoRay follows other major Healthcare sector earnings this month
IsoRay's report follows an earnings beat by Merck ADR on September 9, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on August 31 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar